Russell Investments Group, Ltd. - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 52 filers reported holding NEOS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$874,000580,391
+290095.5%
0.00%
Q2 2019$0
-100.0%
200
-99.9%
0.00%
-100.0%
Q3 2018$1,875,000
-51.3%
386,962
-37.1%
0.00%
-50.0%
Q2 2018$3,848,000
-44.1%
615,674
-25.8%
0.01%
-33.3%
Q1 2018$6,884,000
+38.3%
829,298
+65.8%
0.01%
+50.0%
Q4 2017$4,976,000
+98.5%
500,170
+82.5%
0.01%
+100.0%
Q3 2017$2,507,000
+27.2%
274,087
+1.5%
0.00%0.0%
Q2 2017$1,971,000
+171.9%
270,020
+167.9%
0.00%
+300.0%
Q1 2017$725,000
+33.0%
100,783
+15.5%
0.00%0.0%
Q4 2016$545,00087,2560.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,971,014$6,413,0004.42%
SPHERA FUNDS MANAGEMENT LTD. 3,711,454$4,788,0000.66%
Proxima Capital Management, LLC 206,000$266,0000.36%
Nantahala Capital Management 4,610,000$5,947,0000.18%
Alambic Investment Management, L.P. 219,090$283,0000.18%
Wealthstar Advisors, LLC 73,295$95,0000.06%
ALGERT GLOBAL LLC 77,845$100,0000.04%
Western Standard LLC 25,935$33,0000.02%
Allred Capital Management, LLC 24,995$33,0000.02%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 320,993$414,0000.02%
View complete list of NEOS THERAPEUTICS INC shareholders